期刊文献+

二甲双胍抑制乳腺癌MCF-7细胞作用的研究 被引量:5

Inhibitory effects of metformin on breast cancer cell line MCF-7
下载PDF
导出
摘要 目的初步探讨二甲双胍对乳腺癌MCF-7细胞的抑制作用。方法将乳腺癌MCF-7细胞分为实验组和对照组,实验组用终浓度为16.56g/L的二甲双胍培养,对照组不用二甲双胍干预。两组MCF-7细胞在相同条件下培养48h后分别提取细胞总蛋白,应用Western blot法检测乳腺癌MCF-7细胞中NF-κBp65、Lin28B的表达情况。以RT-PCR法检测MCF-7细胞中microRNA let-7下游基因HMGA2、H-Ras的转录水平。结果药物干预48h后,乳腺癌MCF-7细胞中NF-κBp65、Lin28B的表达水平下降,差异有统计学意义(P<0.05)。实验组乳腺癌MCF-7细胞中自我复制和多向分化的相关基因HMGA2、H-Ras的转录水平明显下降,2-△△Ct测得两种基因的表达分别下降85%和96%(P均<0.05)。结论 16.56g/L的二甲双胍能够有效地降低乳腺癌MCF-7细胞中NF-κBp65、Lin28B的表达,进一步抑制乳腺癌MCF-7细胞多向分化和自我复制相关基因HMGA2和H-Ras的表达,从而为二甲双胍抑制乳腺癌的复发和转移提供实验依据。 Objective To explore the mechanism of metformin in inhibiting breast cancer cell line MCF-7. Methods MCF-7 cells were cultured for 48 h in the presence or absence of 16.56 g/L metformin,total protein was extracted from cells and expression of nu- clear factor-kappa B(NF-KB) p65 and Lin28B were detected by Western blot. Furthermore, transcription levels of HMGA2 and H-Ras, which are regulated by microRNA let-7,were determined by RT-PCR. Results NF-KB p65 and Lin28B expression declined signifi- cantly after 48-h drug treatment(t=23.44, t= 14.24;P〈0.05 ).Transcription levels of HMGA2 and H-Ras,which are related to self-renewal and multipotent differentiation of tumor cells,decreased 85%(P〈0.05) and 96%(P〈0.05), respectively, based on 2-△△Ct measurements. Conclusions Metformin at 16.56 g/L can effectively reduce NF-KB and Lin28B expression and inhibit HMGA2 and H-Ras transcrip- tion in MCF-7 cells.These findings suggest that metformin inhibits breast cancer at the cellular level.
出处 《中国癌症防治杂志》 CAS 2013年第2期126-129,共4页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
关键词 乳腺肿瘤 二甲双胍 NF-ΚBP65 Lin28B HMGA2 H-RAS Breast neoplasms Metformin NF-KB p65 Lin28B HMGA2 H-Ras
  • 相关文献

参考文献13

  • 1Brown KA,Hunger NI,Docanto M,et al.Metformin inhibits aromataseexpression in human breast adipose stromal cells via stimulation ofAMP-activated protein kinase[j].Breast Cancer Research and Treatt,2010,123(2):591-596.
  • 2Bosco JL,Antonsen S,S0rensen HT,et al.Metformin and incidentbreast cancer among diabetic women: A population-based case -contral study in Denmark [j ] .Cancer Epidemiol Biomarkers Preven-tion,2011,20( 1 ) : 101-111.
  • 3Shi M,Liu D,Duan H,et al.Metastasis-related miRNAs,active play-ers in bresst cancer invasion,and metastasis [ J ] . Cancer MetastasisReviews,2010,29(4) :785-799.
  • 4Goodwin PJ,Stambolic V.Obesity and insulin resistance in breastcancer-Chemoprevention strategies with a focus on metformin [j].Breast,2011,20 (Suppl 3):S31-35.
  • 5Oliveras-Ferraros C,Cufl S, Vazquez-Martin A,et al.MicroRNA ex-pression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin : induction of the tumor suppressor miRNAlet-7a and suppression of the TGF (. -induced oncomiR miRNA-181a[j].Cell Cycle,2011,10(7):1144-1151.
  • 6Cufl S,Vazquez-Martin A,Oliveras-Ferraros C,et al.Metformin a-gainst TGF 3 -induced epithelial-to-mesenchymal transition (EMT):from cancer stem cells to aging-associated fibrosis[j].Cell Cycle,2010,9(22):4461-4468.
  • 7Xu T,Zhu Y,Wei QK,et al.A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma[j].Carcinogenesis,2008,29( 11 ):2126-2131.
  • 8Kim HG, Hien TT, Han EH, et al.Metformin inhibits p-glyco-protein expression via the NF- kB pathway and CRE transcrip-tional activity through AMPK activation [ J ] .British Journal of Phar-macology ,2011,162(5):1096-1108.
  • 9Iliopoulos D,Hirsch HA,Struhl K.An epigenetic switch involvingNF- kB,Lin28,let-7 microRNA,and IL-6 links inflammation to celltransformation [j] .Cell,2009,139(4) : 693-706.
  • 10Piskounova E,Polytarchou C,Thornton JE,et al.Lin28A and lin28Binhibit let-7 microRNA biogenesis by distinct mechanisms [ J ] .Cell,2011,147(5):1066-1079.

同被引文献89

  • 1Liao, Quan,Zhao, Yu-Pei,Yang, Ying-Chi,Li, Li-Jun,Long, Xiao,Han, Shao-Mei.Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):641-645. 被引量:27
  • 2Li X,Zhang N,Li Y,et al.Effects of metformin and rosiglitazone on peripheral insulin resistance and beta-cell function in obesity:a double-blind,randomized,controlled study[J].J Int Med Res,2011,39(2):358-365.
  • 3Aljada A,Mousa SA.Metformin and neoplasia:implications and indications[J].Pharmacol Ther,2012,133(1):108-115.
  • 4Senior PA.Type 2diabetes,metformin and lactic acidosis-defining the risk and promoting safe practice[J].Diabet Med,2012,29(2):161-163.
  • 5Bodmer M,Meier C,Krahenbuhl S,et al.Long-term metformin use is associated with decreased risk of breast cancer[J].Diabetes Care,2010,33(6):1304-1308.
  • 6Leone A,Di Gennaro E,Bruzzese F,et al.New perspective for an old antidiabetic drug:metformin as anticancer agent[J].Cancer Treat Res,2014,159:355-376.
  • 7Chen TW,Liang YN,Feng D,et al.Metformin inhibits proliferation and promotes apoptosis of HER2positive breast cancer cells by downregulating HSP90[J].J BUON,2013,18(1):51-56.
  • 8Ben SI,Laurent K,Giuliano S,et al.Targeting cancer cell metabolism:the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells[J].Cancer Res,2010,70(6):2465-2475.
  • 9Zhao CB,Bao JM,Lu YJ,et al.Co-expression of RAGE and HMGB1is associated with cancer progression and poor patient outcome of prostate cancer[J].Am J Cancer Res,2014,4(4):369-377.
  • 10Wang X,Cui E,Zeng H,et al.RAGE genetic polymorphisms are associated with risk,chemotherapy response and prognosis in patients with advanced NSCLC[J].PLo S One,2012,7(10):e43734.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部